As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...

Data presented at WODC USA 2026 Support Potential Application Across Multiple Indications, Including Pitt-Hopkins Syndrome, Fragile X Syndrome, and Rett Syndrome Restoration of Cognitive and ...

JW Pharmaceutical (KRX:001060) presented preclinical findings and its global development strategy for DDC-02, a therapeutic candidate for rare neurodevelopmental disorders, at the World Orphan Drug ...

Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

JW Pharmaceutical has announced its preclinical findings and global development strategy for DDC-02, a therapeutic candidate for rare neurodevelopmental disorders, at the World Orphan Drug Congress ...

New preclinical data will guide antigen selection for a broadly protective cytomegalovirus vaccine candidatePoster presentation on July 12, 2026, ...

The EoE-centered framework supports disease modeling, multidimensional efficacy endpoints, type 2 biomarker analysis, and cross-indication translational research ...

An international research team led by investigators in the Department of Microbiology at the Icahn School of Medicine at ...

Along with fellow LNP Alliance members, NOF Corporation and Neosome Life Sciences, Phosphorex is hosting a free, one-hour virtual discussion entitled, "Streamline Targeted LNP Development to Improve ...

The FDA provided favorable feedback on NewcelX’s Chemistry, Manufacturing, and Controls (“CMC”) processes and preclinical program allowing the Company to proceed toward its Investigational New Drug ...